ALISO VIEJO, Calif., May 27, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO), a company that manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, today announced that the District Court issued an order relating to the lawsuit filed by Hologic and its wholly-owned subsidiaries, Cytyc Corporation and Cytyc LP, asserting claims of patent infringement, unfair competition and false advertising against SenoRx.
